Latest News & Updates
Breaking News
21 hours ago
Simantini Singh Deo
Other trending news you may like to read
Takeda Gains FDA Supplemental Approval for HYQVIA in CIDP Maintenance Therapy June 2026
FDA issues fourth supplemental approval for Takeda's HYQVIA, adding CIDP maintenance therapy to its labeled indications as of June 11, 2026.
Simantini Singh Deo
Roche Gains FDA Approval for First PTEN-Loss Companion Diagnostic in Prostate Cancer
Roche's FDA approval of the first PTEN-loss companion diagnostic sets a new co-development and labeling benchmark for prostate cancer drug-diagnostic programmes.
Simantini Singh Deo
Lilly's Jaypirca Achieves 45% Progression Risk Reduction in Phase 3 CLL Trial
Lilly's Jaypirca cuts progression risk by 45% in Phase 3 CLL trial, signaling label expansion with manufacturing scale-up implications.
Simantini Singh Deo
Alithea Genomics Signs Deal with Revvity to Scale Transcriptomic Profiling in Drug Discovery
Alithea Genomics and Revvity integrate MERCURIUS DRUG-seq into a global screening portfolio to scale transcriptomic profiling in early drug discovery.
Simantini Singh Deo
